675 related articles for article (PubMed ID: 22178619)
1. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
2. Fast drying of biocompatible polymer films loaded with poorly water-soluble drug nano-particles via low temperature forced convection.
Susarla R; Sievens-Figueroa L; Bhakay A; Shen Y; Jerez-Rozo JI; Engen W; Khusid B; Bilgili E; Romañach RJ; Morris KR; Michniak-Kohn B; Davé RN
Int J Pharm; 2013 Oct; 455(1-2):93-103. PubMed ID: 23911341
[TBL] [Abstract][Full Text] [Related]
3. Polymer strip films as a robust, surfactant-free platform for delivery of BCS Class II drug nanoparticles.
Krull SM; Susarla R; Afolabi A; Li M; Ying Y; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2015 Jul; 489(1-2):45-57. PubMed ID: 25888803
[TBL] [Abstract][Full Text] [Related]
4. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.
Krull SM; Ma Z; Li M; Davé RN; Bilgili E
Drug Dev Ind Pharm; 2016; 42(7):1073-85. PubMed ID: 26567632
[TBL] [Abstract][Full Text] [Related]
6. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
7. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.
Krull SM; Patel HV; Li M; Bilgili E; Davé RN
Eur J Pharm Sci; 2016 Sep; 92():146-55. PubMed ID: 27402100
[TBL] [Abstract][Full Text] [Related]
8. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.
Krull SM; Moreno J; Li M; Bilgili E; Davé RN
Int J Pharm; 2017 May; 523(1):33-41. PubMed ID: 28315716
[TBL] [Abstract][Full Text] [Related]
9. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
[TBL] [Abstract][Full Text] [Related]
10. Atomistic simulation study of surfactant and polymer interactions on the surface of a fenofibrate crystal.
Zhu W; Romanski FS; Meng X; Mitra S; Tomassone MS
Eur J Pharm Sci; 2011 Apr; 42(5):452-61. PubMed ID: 21291999
[TBL] [Abstract][Full Text] [Related]
11. Complementary near-infrared and Raman chemical imaging of pharmaceutical thin films.
Rozo JI; Zarow A; Zhou B; Pinal R; Iqbal Z; Romañach RJ
J Pharm Sci; 2011 Nov; 100(11):4888-95. PubMed ID: 21656518
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of surface-modified dry micronized poorly water-soluble drug powders into polymer strip films.
Zhang L; Li Y; Abed M; Davé RN
Int J Pharm; 2018 Jan; 535(1-2):462-472. PubMed ID: 29170115
[TBL] [Abstract][Full Text] [Related]
15. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
16. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants.
Bhakay A; Azad M; Vizzotti E; Dave RN; Bilgili E
Drug Dev Ind Pharm; 2014 Nov; 40(11):1509-22. PubMed ID: 23981202
[TBL] [Abstract][Full Text] [Related]
17. Zero-order release of poorly water-soluble drug from polymeric films made via aqueous slurry casting.
Zhang L; Alfano J; Race D; Davé RN
Eur J Pharm Sci; 2018 May; 117():245-254. PubMed ID: 29499350
[TBL] [Abstract][Full Text] [Related]
18. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
Karavas E; Georgarakis M; Docoslis A; Bikiaris D
Int J Pharm; 2007 Aug; 340(1-2):76-83. PubMed ID: 17478064
[TBL] [Abstract][Full Text] [Related]
19. Stable carbamazepine colloidal systems using the cosolvent technique.
Douroumis D; Fahr A
Eur J Pharm Sci; 2007 Apr; 30(5):367-74. PubMed ID: 17234395
[TBL] [Abstract][Full Text] [Related]
20. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
Monteiro A; Afolabi A; Bilgili E
Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]